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18. TRENDS IN NONMELANOMA SKIN CANCER MORTALITY IN THE UNITED STATES,
1969 THROUGH 2000
Kevan G. Lewis, MD, and Martin A. Weinstock, MD, PhD
Dermatoepidemiology Unit, Veterans Affairs Medical Center and Brown Medical School,
Department of Dermatology, Providence, Rhode Island, USA.
Objectives: The purpose of this study was to investigate mortality from nonmelanoma skin
cancer (NMSC) in the United States and to assess trends over time. Particular emphasis was
placed on the subgroup of NMSC arising on genital skin.
Methods: A population-based study of NMSC mortality in the United States from 1969 to
2000 based on records from the U.S National Center for Health Statistics and the Centers for
Disease Control mortality databases.
Results: More than 75,000 deaths in the U.S. were attributed to NMSC from 1969 to 2000.
The age-adjusted U.S. mortality rate for NMSC arising on nongenital skin was 0.72 (/100,000/
yr); the rate among men was twice that among women. Nongenital NMSC mortality among
white men exceeded that of black men by more than a factor of two, whereas rates for white
and black women were similar. Nongenital NMSC mortality declined over time in all sub-
groups examined. Rates among men declined steadily over time excepting the years 1981 to
1986 during which a sharp but temporary increase was noted, the cause of which was likely
artifactual. The decline in women was greatest during the 1970s; subsequently rates have
held steady. Corresponding mortality rates for NMSC arising on genital skin (penis, scrotum,
vulva) were 0.30 in men and 0.55 in women. In contrast to nongenital NMSC, mortality from
genital NMSC was two-fold greater among black men than among white men; again rates for
white and black women were similar. Genital NMSC mortality declined over time in all sub-
groups examined, but most demonstrably in black men. The decline among women was
greatest during the 1970s after which rates held relatively steady.
Conclusions: Mortality from NMSC in the United States is significant, and NMSC arising on
genital skin contributes a large proportion of deaths overall. The dermatology community
should place greater emphasis on reducing mortality from genital NMSC while continuing to
stress reduction of excess sun exposure. Education of health care practitioners in related
medical specialties on the risk of mortality from genital NMSC is also warranted.
19. TANNING FACILITY YOUTH ACCESS AND SKIN CANCER INFORMATION PRACTICES
IN FOUR US STATES
R. P. Dellavalle, E. J. Hester, L. F. Heilig, R. D’Ambrosia, A. L. Drake, L. M. Schilling
Depts. of Dermatology, Medicine, and Preventive Medicine and Biometrics, U. of Colorado
Health Sciences Center, Denver, CO, 80262, and the Veterans Affairs Medical Center,
Denver, CO, 80220, USA.
Objectives: Ultraviolet radiation (UV) tanning bed use is associated with skin cancer. While
47 US states do not set age limits for tanning patrons, three states do: Texas (age 13), Illinois
(age 14), and Wisconsin (age 16). This study set out to describe youth access, frequency of
youth discount pricing incentives, and skin cancer risk information provided by tanning fa-
cilities in 4 states with different UV tanning age restrictions.
Methods: The study utilized an anonymous telephone cross-sectional survey to 400 ran-
domly selected tanning facilities in Colorado (CO), Texas (TX), Illinois (IL), and Wisconsin (WI).
The Colorado Multiple Institutional Review Board approved the protocol. Main outcome
measures were percentage of facility operators: 1) permitting indoor UV tanning in violation of
state regulations for a potential 12-year-old patron and 15-year-old patron, 2) offering youth
discounts, and 3) stating that UV tanning is not a risk factor for skin cancer.
Results: For 12-year-olds, 18% of facilities in Colorado, 23% in Texas, 74% in Illinois, and
89% in Wisconsin had an operator report that they would not permit indoor UV tanning. For
15-year-olds, 44% of facilities had an operator report that they would permit youth access
violating current regulations (TX 83% (access without guardian accompaniment), Illinois 20%
(access without guardian consent), Wisconsin 17% (underage access)). Overall 15% of op-
erators offered youth discounts (CO 11%, TX 23%, IL 14%, WI 11%), and 24% denied that
UV tanning was a skin cancer risk factor (CO 31%, TX 28%, IL 13%, WI 23%).
Conclusions: UV tanning youth access correlated with the strength of youth access reg-
ulation and was least restricted in Colorado, a state without youth access regulations, and in
Texas, the state with the lowest and most recently enacting age regulation (2002). Facilities
offering youth discounts and denying that UV tanning increases skin cancer risk were
detected in all four states: a discovery that suggests targets for further tanning industry
regulatory measures.
20. CLINICAL RISK FACTORS FOR SKIN CANCER IN A COHORT OF KIDNEY AND HEART
TRANSPLANT RECIPIENTS: A CASE CONTROL STUDY
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Riuniti di Bergamo - Bergamo - Italy.
Introduction: Organ transplant recipients are at high risk of skin cancer. Multiple risk fac-
tors (iatrogenic immunosuppression, follow-up time, age at transplantation, etc.) have been
extensively reported in the literature. Only a few data about Mediterranean and Italian people
are available.
Methods: A case-control study was developed. From 1997 all the renal (RTR) and heart
(HTR) transplant patients with histologically proven skin cancer entered into the present
study. Each patient (case) was matched with two transplanted patients with the same type of
organ, sex, and follow-up time, but free of skin cancer (controls). After informed consent, a
trained dermatologist made a full skin examination and a detailed interview about some
possible risk factors (sun exposure for job or leisure, holidays, personal or family history of
cancer etc.). T test for independent samples and &#967;2 test were used for statistical
analysis. Multivariate analysis will be made with conditioned logistic regression. Collection of
cases and controls is in progress; we present only preliminary data.
Results: We collected 229 patients (189 RTR , 40 HTR). They were 91 cases (76M, 15F) and
138 controls (118 M , 20 F). mean age (years) at the visit was 56,9 SD 10,1 (60,8 SD 8,1 cases,
54,3 SD 10.3 controls). Age at transplantation was 47,8 SD 10.5 for cases and 41.0 SD 12.9
for controls (po0.0001). Mean follow up time (years) was 14,4 SD 9.1. Mean follow up time
(years) at the diagnosis of the cancer was 7.4 SD 5.4 (range 0-21.7 years). 41/91 patients had
a second cancer after 2.1 SD 2.5 years from the first one and 19/41 had a third cancer.
Patients with cancer were more prone to have fair skin (po0.02), elastosis (po0.00001)
actinic keratoses anywhere (po0.001), on the face (po0.008) and on the arms (po0.005). No
differences between cases and controls were found about hair colour (p¼ 0.373) eye colour
(p¼ 0.444), solar lentigo (p¼0.284), number of nevi on the upper arm (p¼0.515).
Discussion: Age at transplantation fair skin, actinic keratoses and elastosis are important risk
factors for skin cancer among organ transplant recipients. Patients with a first cancer are at
high risk for sub-sequent cancers. Further data will be obtained after ending data collection
and multivariate analysis. An accurate clinical follow up of all transplanted patient is needed.
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